A. J. Gelderblom

Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer

T. H. van Dijk, K Tamás, Jannet C. Beukema et al. · Annals of Oncology · 2013 · 148 citations · Full text

Medicine, Oncology, Surgery +16

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment

Dave E. W. van der Kruijssen, Sjoerd G. Elias, Geraldine R. Vink et al. · JAMA Surgery · 2021 · 53 citations · Full text

Medicine, Oncology, Surgery +17

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group

Dave E. W. van der Kruijssen, Sjoerd G. Elias, Peter M. van de Ven et al. · Annals of Oncology · 2024 · 15 citations · Full text

Medicine, Oncology, Surgery +14

Clinical validation study of genetic markers for capecitabine efficacy in metastatic colorectal cancer patients

Lieke H. van Huis‐Tanja, Ewoud Ewing, R.J.H.M. van der Straaten et al. · Pharmacogenetics and Genomics · 2015 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17